US Bancorp DE Sells 193 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

US Bancorp DE lowered its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 20.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 734 shares of the medical instruments supplier’s stock after selling 193 shares during the period. US Bancorp DE’s holdings in Utah Medical Products were worth $49,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in UTMD. BNP Paribas Financial Markets raised its stake in shares of Utah Medical Products by 123.0% during the first quarter. BNP Paribas Financial Markets now owns 8,399 shares of the medical instruments supplier’s stock valued at $597,000 after acquiring an additional 4,633 shares during the last quarter. Vanguard Group Inc. raised its position in Utah Medical Products by 7.3% during the 1st quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock valued at $13,023,000 after purchasing an additional 12,402 shares during the last quarter. EntryPoint Capital LLC lifted its holdings in Utah Medical Products by 124.1% in the 1st quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier’s stock worth $230,000 after buying an additional 1,794 shares during the period. Quadrature Capital Ltd grew its position in shares of Utah Medical Products by 177.6% in the 1st quarter. Quadrature Capital Ltd now owns 32,310 shares of the medical instruments supplier’s stock worth $2,294,000 after buying an additional 20,671 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Utah Medical Products by 4.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 22,941 shares of the medical instruments supplier’s stock valued at $1,632,000 after buying an additional 947 shares during the period. Institutional investors own 69.60% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Stock Performance

UTMD stock opened at $66.05 on Monday. Utah Medical Products, Inc. has a fifty-two week low of $63.38 and a fifty-two week high of $87.21. The company has a market capitalization of $223.91 million, a price-to-earnings ratio of 15.47 and a beta of 0.08. The business’s 50 day moving average price is $66.03 and its two-hundred day moving average price is $67.34.

Utah Medical Products Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 3rd. Shareholders of record on Monday, December 16th will be issued a $0.305 dividend. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Monday, December 16th. This represents a $1.22 dividend on an annualized basis and a yield of 1.85%. Utah Medical Products’s dividend payout ratio is 28.10%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.